Cargando…

Epstein-Barr virus encoded latent membrane protein 1 suppresses necroptosis through targeting RIPK1/3 ubiquitination

Necroptosis is an alternative programmed cell death pathway that is unleashed in the absence of apoptosis and mediated by signaling complexes containing receptor-interating protein kinase 1 (RIPK1) and RIPK3. This form of cell death has recently been implicated in host defense system to eliminate pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiaolan, Li, Yueshuo, Peng, Songling, Yu, Xinfang, Li, Wei, Shi, Feng, Luo, Xiangjian, Tang, Min, Tan, Zheqiong, Bode, A. M., Cao, Ya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833833/ https://www.ncbi.nlm.nih.gov/pubmed/29352166 http://dx.doi.org/10.1038/s41419-017-0081-9

Ejemplares similares

Neoalbaconol induces cell death through necroptosis by regulating RIPK-dependent autocrine TNFα and ROS production
por: Yu, Xinfang, et al.
Publicado: (2014)

Targeting the signaling in Epstein–Barr virus-associated diseases: mechanism, regulation, and clinical study
por: Cao, Ya, et al.
Publicado: (2021)

Anoikis resistance and immune escape mediated by Epstein-Barr virus-encoded latent membrane protein 1-induced stabilization of PGC-1α promotes invasion and metastasis of nasopharyngeal carcinoma
por: Liao, Chaoliang, et al.
Publicado: (2023)

DNMT1 mediates metabolic reprogramming induced by Epstein–Barr virus latent membrane protein 1 and reversed by grifolin in nasopharyngeal carcinoma
por: Luo, Xiangjian, et al.
Publicado: (2018)

Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis
por: Li, Hongde, et al.
Publicado: (2016)

EBV(LMP1)-induced metabolic reprogramming inhibits necroptosis through the hypermethylation of the RIP3 promoter
por: Shi, Feng, et al.
Publicado: (2019)

Therapies based on targeting Epstein‐Barr virus lytic replication for EBV‐associated malignancies
por: Li, Hongde, et al.
Publicado: (2018)

Epstein‐Barr virus‐encoded latent membrane protein 1 promotes extracellular vesicle secretion through syndecan‐2 and synaptotagmin‐like‐4 in nasopharyngeal carcinoma cells
por: Liao, Chaoliang, et al.
Publicado: (2020)

Wild-type IDH2 contributes to Epstein–Barr virus-dependent metabolic alterations and tumorigenesis
por: Shi, Feng, et al.
Publicado: (2020)

Necroptosis: Fifty shades of RIPKs
por: Ichim, Gabriel, et al.
Publicado: (2014)

The ubiquitin-modifying enzyme A20 restricts the ubiquitination of RIPK3 and protects cells from necroptosis
por: Onizawa, Michio, et al.
Publicado: (2015)

Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy
por: Hu, Jianmin, et al.
Publicado: (2020)

PGC1α/CEBPB/CPT1A axis promotes radiation resistance of nasopharyngeal carcinoma through activating fatty acid oxidation
por: Du, Qianqian, et al.
Publicado: (2019)

Secretion of Epstein-Barr Virus-encoded BARF1 oncoprotein from latently infected B cells
por: Fiorini, Sylvie, et al.
Publicado: (2008)

RIPK1 prevents aberrant ZBP1-initiated necroptosis
por: Berghe, Tom Vanden, et al.
Publicado: (2016)

Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy: Erratum
por: Hu, Jianmin, et al.
Publicado: (2022)

Tyrosylprotein Sulfotransferase-1 and Tyrosine Sulfation of Chemokine Receptor 4 Are Induced by Epstein-Barr Virus Encoded Latent Membrane Protein 1 and Associated with the Metastatic Potential of Human Nasopharyngeal Carcinoma
por: Xu, Juan, et al.
Publicado: (2013)

Epstein–Barr virus latent genes
por: Kang, Myung-Soo, et al.
Publicado: (2015)

Therapeutic Evaluation of Epstein-Barr Virus-encoded Latent Membrane Protein-1 Targeted DNAzyme for Treating of Nasopharyngeal Carcinomas
por: Cao, Ya, et al.
Publicado: (2014)

Polarity protein AF6 functions as a modulator of necroptosis by regulating ubiquitination of RIPK1 in liver diseases
por: Xinyu, Wang, et al.
Publicado: (2023)

RIPK1–RIPK3–MLKL-Associated Necroptosis Drives Leishmania infantum Killing in Neutrophils
por: Barbosa, Laiana A., et al.
Publicado: (2018)

Overexpression of Epstein-Barr virus-encoded latent membrane protein-1 (LMP-1) in oral squamous cell carcinoma
por: Rahman, Rifat, et al.
Publicado: (2019)

Assessment of the prognostic impact of the Epstein–Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease
por: Glavina-Durdov, M, et al.
Publicado: (2001)

Necroptosis induced by RIPK3 requires MLKL but not Drp1
por: Moujalled, D M, et al.
Publicado: (2014)

ZBP1 not RIPK1 mediates tumor necroptosis in breast cancer
por: Baik, Jin Young, et al.
Publicado: (2021)

TRAF6 regulates the abundance of RIPK1 and inhibits the RIPK1/RIPK3/MLKL necroptosis signaling pathway and affects the progression of colorectal cancer
por: Lin, Penghang, et al.
Publicado: (2023)

Furosine, a Maillard Reaction Product, Triggers Necroptosis in Hepatocytes by Regulating the RIPK1/RIPK3/MLKL Pathway
por: Li, Huiying, et al.
Publicado: (2019)

Lysosomal damage after spinal cord injury causes accumulation of RIPK1 and RIPK3 proteins and potentiation of necroptosis
por: Liu, Shuo, et al.
Publicado: (2018)

Necrostatin-1 Prevents Necroptosis in Brains after Ischemic Stroke via Inhibition of RIPK1-Mediated RIPK3/MLKL Signaling
por: Deng, Xu-Xu, et al.
Publicado: (2019)

Vemurafenib inhibits necroptosis in normal and pathological conditions as a RIPK1 antagonist
por: Sun, Mayu, et al.
Publicado: (2023)

Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death
por: Moriwaki, K, et al.
Publicado: (2015)

Catecholamine Surges Cause Cardiomyocyte Necroptosis via a RIPK1–RIPK3-Dependent Pathway in Mice
por: Wu, Penglong, et al.
Publicado: (2021)

MG53 Inhibits Necroptosis Through Ubiquitination-Dependent RIPK1 Degradation for Cardiac Protection Following Ischemia/Reperfusion Injury
por: Wang, Qiang, et al.
Publicado: (2022)

DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomas
por: Liao, Wei-Hua, et al.
Publicado: (2014)

Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma
por: Vrzalikova, Katerina, et al.
Publicado: (2018)

Ubiquitination of RIPK1 suppresses programmed cell death by regulating RIPK1 kinase activation during embryogenesis
por: Zhang, Xixi, et al.
Publicado: (2019)

Epstein‐Barr Virus‐encoded Latent Membrane Protein 1 Co‐expresses with Epidermal Growth Factor Receptor in Nasopharyngeal Carcinoma
por: Sheen, Tzung‐Shiahn, et al.
Publicado: (1999)

ZEB1 Regulates the Latent-Lytic Switch in Infection by Epstein-Barr Virus
por: Yu, Xianming, et al.
Publicado: (2007)

Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma
por: Salano, Valerie E., et al.
Publicado: (2021)

T1AM Attenuates the Hypoxia/Reoxygenation-Induced Necroptosis of H9C2 Cardiomyocytes via RIPK1/RIPK3 Pathway
por: Wei, Bo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8prm16t7emklqm61v9i22ef59j